On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.

On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.